Back to top

Spectral Medical Advances PMX Toward FDA Submission After Positive Tigris Results

Spectral Medical ( ($TSE:EDT) ) has shared an announcement. Spectral Medical reported its fourth quarter and full-year 2025 results alongside a cor...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Spectral Diagnostics Inc. (EDTXF)